Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma

NCT04577326 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Malignant Pleural Mesothelioma (MPM)

Interventions

DRUG: cyclophosphamide
BIOLOGICAL: CAR T cells

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]